GLMD icon

Galmed Pharmaceuticals

20 hedge funds and large institutions have $5.93M invested in Galmed Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 2 closing their positions.

Holders
20
Holders Change
-1
Holders Change %
-4.76%
% of All Funds
0.53%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
6
Reduced
4
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
6CM
1
683 Capital Management
New York
$2.01M 264,600
PWAM
2
Park West Asset Management
California
$1.56M 205,500
PA
3
Perceptive Advisors
New York
$571K 75,000
KCM
4
Knoll Capital Management
Florida
$495K 65,000
Vanguard Group
5
Vanguard Group
Pennsylvania
$242K 31,794 +2,576 +9%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$223K 29,374 +2,105 +8%
SKK
7
Shepherd Kaplan Krochuk
Massachusetts
$142K 18,690 -18,690 -50%
MC
8
Menta Capital
California
$129K 16,948 +1,160 +7%
Goldman Sachs
9
Goldman Sachs
New York
$115K 15,052 -19,061 -56%
CA
10
CapWealth Advisors
Tennessee
$91K 12,000
DCM
11
DAFNA Capital Management
California
$91K 11,988 +6,117 +104%
BIT
12
BlackRock Institutional Trust
California
$88K 11,602
Morgan Stanley
13
Morgan Stanley
New York
$48K 6,351 -364 -5%
Acadian Asset Management
14
Acadian Asset Management
Massachusetts
$39K 5,176 -1,617 -24%
UBS Group
15
UBS Group
Switzerland
$35K 4,619 +2,964 +179%
BA
16
BlackRock Advisors
Delaware
$16K 2,061
EDRH
17
Edmond de Rothschild Holding
Switzerland
$7K 916
EDRE
18
Edmond de Rothschild (Europe)
Luxembourg
$7K 916
BFA
19
BlackRock Fund Advisors
California
$7K 876 +876 New
Bank of America
20
Bank of America
North Carolina
$4K 498 +38 +8%
Royal Bank of Canada
21
Royal Bank of Canada
Ontario, Canada
-3,250 Closed
TRCT
22
Tower Research Capital (TRC)
New York
-90 Closed